KOD Earnings Date: Nov 12, 2026 (Estimated) — Kodiak Sciences Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is KOD's next earnings date?
Kodiak Sciences Inc. (KOD) is expected to report Q3 2026 earnings on Thursday, November 12, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$1.06.
How did KOD do in its last earnings report?
In its most recent report on Aug 13, 2026 (Q2 2026), Kodiak Sciences Inc. posted EPS of -$1.05 versus the -$0.96 estimate, a miss of 9.4%. Revenue was $0. The stock's 1-day post-earnings move was +3.4%.
How much does KOD stock move after earnings?
KOD beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 6.5% (up or down) in the day after earnings.
About Kodiak Sciences Inc.
Kodiak Sciences Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering, advancing, and bringing to market treatments for various conditions affecting the retina. Their primary drug candidate, KSI-301, is an anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer. This compound is currently undergoing Phase IIb/III clinical trials, targeting illnesses such as wet age-related macular degeneration (AMD), diabetic macular edema, previously untreated macular edema resulting from retinal vein occlusion, and non-proliferative diabetic retinopathy. In its earlier, preclinical development pipeline, the company is also working on KSI-501, a bispecific conjugate designed for retinal conditions involving inflammation, and KSI-601, a triplet inhibitor aimed at addressing dry AMD. Established in 2009, this Palo Alto, California-based company operated under the name Oligasis, LLC before rebranding as Kodiak Sciences Inc. in September 2015.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | Q2 2026 | -0.96 | -1.05 | -9.38% | $0 | ❌ Miss | +3.43% | -0.35% | -17.11% |
| 2026-08-12 | -0.96 | -1.05 | -9.78% | — | ❌ Miss | -5.06% | -3.47% | -21.94% | |
| 2026-05-18 | Q1 2026 | -1.00 | -0.94 | +6.00% | $0 | ✅ Beat | -1.71% | +2.80% | +1.97% |
| 2026-03-31 | Q4 2025 | -1.04 | -1.04 | +0.00% | $0 | ➖ Inline | +12.30% | +9.65% | +14.06% |
| 2025-11-13 | Q3 2025 | -1.05 | -1.16 | -10.48% | $0 | ❌ Miss | +3.39% | +3.82% | +21.99% |
| 2025-08-13 | Q2 2025 | -1.03 | -1.03 | +0.00% | — | ➖ Inline | +16.47% | +10.21% | +7.31% |
| 2025-03-27 | Q4 2024 | -0.86 | -0.84 | +2.33% | $0 | ✅ Beat | -4.90% | -21.57% | +37.58% |
| 2024-11-14 | Q3 2024 | -0.90 | -0.84 | +6.67% | $0 | ✅ Beat | +4.34% | +11.32% | +53.21% |
Showing last 8 quarters.